Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Determining Metabolic Effects of Valproate and Antipsychotic Therapy [NA]
A completed clinical trial investigated metabolic effects of valproate combined with antipsychotic therapy in schizophrenia; results posted …
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Study of Lurasidone HCl in Subjects With Schizophrenia [Phase 4]
Phase 4 trial assessing lurasidone hydrochloride in adults with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Phase 2 Trial of a Nicotinic Agonist in Schizophrenia [Phase 2]
Phase 2 trial update for a nicotinic agonist in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up [Phase 4]
Phase 4 clinical trial update assessing neurocognitive effectiveness in treatment of first-episode non-affective psychosis with a 3-year fol…
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia [Phase 4]
Phase 4 trial update evaluating selective estrogen receptor modulators for women of child-bearing age with schizophrenia or schizoaffective …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia [Phase 3]
Open-label, long-term Phase 3 trial assessing aripiprazole intramuscular depot in schizophrenia; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Long-term Trial of OPC-34712 in Patients With Schizophrenia [Phase 3]
A long-term Phase 3 clinical trial of OPC-34712 in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Clozapine for Cannabis Use in Schizophrenia [Phase 4]
Phase 4 trial updates the use of clozapine for cannabis use in individuals with schizophrenia; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Pediatric Open-Label Extension Study [Phase 3]
Phase 3 pediatric open-label extension study completed; results posted in 2019 for schizophrenia and autism conditions.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness [NA]
Clinical trial update describing a concierge model of CAE plus long-acting injectable in individuals with schizophrenia at risk for treatmen…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia [NA]
Open-label study investigating intranasal oxytocin for schizophrenia has terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia [Phase 3]
Phase 3 trial of Lu AF35700 in treatment-resistant schizophrenia completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Theta Burst Stimulation for Schizophrenia [NA]
A completed clinical trial evaluating theta burst stimulation for schizophrenia and schizoaffective disorder; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Antipsychotic Effects of Oxytocin [NA]
A terminated clinical trial evaluating antipsychotic effects of oxytocin in schizophrenia with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder [Phase 4]
Phase 4 trial evaluating all-cause hospitalizations for Abilify MyCite users versus virtual matched controls in adults with schizophrenia, b…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: A Study of Staccato Loxapine (ADASUVE®) for Inhalation [Phase 3]
Phase 3 study update for Staccato Loxapine (ADASUVE) inhalation addressing psychomotor agitation and schizophrenia (potentially bipolar diso…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Reducing Cardiovascular Risk in Adults With Serious Mental Illness [NA]
Clinical trial update on reducing cardiovascular risk in adults with serious mental illness; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Aerobic Exercise for Cognition in Schizophrenia [NA]
Completed clinical trial evaluating aerobic exercise for cognition in schizophrenia; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia [Phase 2, Phase 3]
A dose-finding study of OPC-34712 in schizophrenia completed (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Glucose and Lipid Metabolism on Antipsychotic Medication [NA]
Clinical trial completed studying glucose and lipid metabolism effects of antipsychotic medication in schizophrenia-related conditions; resu…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Oxytocin Add on Study for Stable Schizophrenic Patients [NA]
A terminated clinical trial investigating oxytocin as an add-on treatment for stable schizophrenia patients; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet [Phase 4]
Phase 4 trial comparing patient preference between conventional oral olanzapine tablets and olanzapine orodispersible tablets in schizophren…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women [Phase 4]
Phase 4 trial evaluating adjunctive selective estrogen receptor modulators for negative and cognitive symptoms in women with schizophrenia h…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Oxytocin as Adjunctive Treatment of Schizophrenia [Phase 2]
Phase 2 trial evaluating oxytocin as an adjunctive treatment for schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: Anti-inflammatories and Adolescent Schizophrenia [Phase 4]
Phase 4 clinical trial update involving anti-inflammatory agents for adolescents with schizophrenia.